Feeds

Annan lines up against US-inspired human cloning ban

Balance at UN tilts in favour of therapeutic?

  • alert
  • submit to reddit

Remote control for virtualized desktops

UN Secretary-General Kofi Annan endorsed therapeutic cloning on Thursday, adding his weight to the UN member countries opposing the US-led campaign to ban all human cloning.

A treaty which would ban the cloning of human being has been in the works since 2001, but arguments over extending this to include therapeutic cloning have stalled it. Therapeutic cloning involves harvesting stem cells (cells that have yet to differentiate into a specific type of cell) from human embryos, for use in research into diseases and injuries, and is supported numerous countries, including the UK.

Therapeutic cloning is legal in the United Kingdom, but "very carefully regulated," as a spokeswoman for the Bioindustry Association (BIA) put it. Kofi Annan's endorsement was described as "very welcome," but she said it was not possible to predict the outcome of the ongoing debate. She added that the UK is against the banning of therapeutic cloning.

The UN currently faces a proposal sponsored by the US, Costa Rica and over 50 other nations banning all human cloning, and this is opposed by proposal endorsing therapeutic cloning from a group consisting of Belgium and 21 other nations.

The issue of a total ban on cloning has become heated in the run-up to the US presidential elections, particularly since the death of Christopher Reeve, who played Superman and advocated therapeutic cloning and stem cell research. His widow, Dana Reeve, on Thursday endorsed John Kerry's campaign for the presidency.

US President George Bush opposes government funding for any research involving the future destruction of human embryos, while John Kerry, the Democratic Party candidate, advocates the pursuit of embryonic stem cell studies.

Bush has restricted the allocation of federal funds to embryonic stem cell batches that existed as of August 2001, but these batches are not appropriate for human therapeutic cloning for several reasons. For the most part they are quite old and so their quality has declined. Some also contain mouse cells as well as human cells.

A date for a vote on the proposed ban has yet to be fixed. ®

Related stories

UN to debate embryo cloning
US science alliance eyes artificial retina
NASA hands out $13.5m for radiation studies
£147.5m boost for British particle accelerators

Intelligent flash storage arrays

More from The Register

next story
Antarctic ice THICKER than first feared – penguin-bot boffins
Robo-sub scans freezing waters, rocks warming models
I'll be back (and forward): Hollywood's time travel tribulations
Quick, call the Time Cops to sort out this paradox!
Your PHONE is slowly KILLING YOU
Doctors find new Digitillnesses - 'text neck' and 'telepressure'
Reuse the Force, Luke: SpaceX's Elon Musk reveals X-WING designs
And a floating carrier for recyclable rockets
Britain's HUMAN DNA-strewing Moon mission rakes in £200k
3 days, and Kickstarter moves lander 37% nearer takeoff
Rosetta science team thinks Philae might come to life in the spring
And disclose the biggest surprise of Comet 67P
Bond villains lament as Wicked Lasers withdraw death ray
Want to arm that shark? Better get in there quick
prev story

Whitepapers

Seattle children’s accelerates Citrix login times by 500% with cross-tier insight
Seattle Children’s is a leading research hospital with a large and growing Citrix XenDesktop deployment. See how they used ExtraHop to accelerate launch times.
Getting started with customer-focused identity management
Learn why identity is a fundamental requirement to digital growth, and how without it there is no way to identify and engage customers in a meaningful way.
Why CIOs should rethink endpoint data protection in the age of mobility
Assessing trends in data protection, specifically with respect to mobile devices, BYOD, and remote employees.
Reg Reader Research: SaaS based Email and Office Productivity Tools
Read this Reg reader report which provides advice and guidance for SMBs towards the use of SaaS based email and Office productivity tools.
Website security in corporate America
Find out how you rank among other IT managers testing your website's vulnerabilities.